GB Sciences, Inc. (GBLX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
GB Sciences Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.085M |
| September 30, 2023 | 0.235M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0013M |
| September 30, 2022 | -0.0303M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.10M |
| December 31, 2021 | 1.449M |
| September 30, 2021 | -0.0559M |
| June 30, 2021 | 0.1574M |
| March 31, 2021 | 0.0609M |
| December 31, 2020 | 3.997M |
| September 30, 2020 | 0.5977M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.016M |
| September 30, 2019 | -0.2971M |
| June 30, 2019 | -0.2577M |
| March 31, 2019 | -0.9049M |
| December 31, 2018 | -1.884M |
| Date | Value |
|---|---|
| September 30, 2018 | -9.346M |
| June 30, 2018 | 1.138M |
| March 31, 2018 | -0.9268M |
| December 31, 2017 | -0.8289M |
| September 30, 2017 | -0.4547M |
| June 30, 2017 | -0.0731M |
| March 31, 2017 | -2.133M |
| December 31, 2016 | -0.9195M |
| September 30, 2016 | 0.0077M |
| June 30, 2016 | -0.8225M |
| March 31, 2016 | 0.0998M |
| December 31, 2015 | -0.0466M |
| September 30, 2015 | -0.2298M |
| June 30, 2015 | -0.2025M |
| March 31, 2015 | -0.0075M |
| December 31, 2014 | -0.5573M |
| September 30, 2014 | -0.0685M |
| June 30, 2014 | -0.0293M |
| March 31, 2014 | -0.0152M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 0.00 |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| Arvinas, Inc. | 54.90M |
| Fulcrum Therapeutics, Inc. | 13.78M |
| Definium Therapeutics, Inc. | -315.46M |